RxDoctor Payments Data

Tiffany Delice, MD

Psychiatry · Valdosta, GANPI 1619976891

Payments from drug & device makers

$750in general payments, 2019–2025

Across 44 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$230
  • AbbVie$98
  • Johnson & Johnson$84
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$74
  • Alkermes, Inc.$56
  • Avanir Pharmaceuticals, Inc.$40
  • plus $168 from 7 others

What the payments were for

  • Food & beverage$72096%
  • Education$304%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$750 in reported general payments places this provider in the 60th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia

Medicare billing

Part B allowed, 2024
$42,919
Medicare patients
95
Services billed
394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuedextaDextromethorphan Hbr/Quinidine34$52,532
NamzaricMemantine Hcl/Donepezil Hcl16$14,564
Chlorpromazine Hcl27$14,396
TrintellixVortioxetine Hydrobromide25$12,846
Lurasidone Hcl14$9,157
Divalproex Sodium ErDivalproex Sodium67$7,461
Divalproex Sodium107$3,277
Ritalin LaMethylphenidate Hcl12$2,959
Quetiapine Fumarate170$2,701
Desmopressin Acetate28$1,902
Venlafaxine Hcl ErVenlafaxine Hcl72$1,560
Risperidone166$1,549
Trazodone Hcl177$1,297
Oxcarbazepine26$1,171
Olanzapine45$1,134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Avanir Pharmaceuticals, Inc.Nuedexta$40$52,53234 claims
AbbVieNamzaric$98$14,56416 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$35$12,84625 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Valdosta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →